Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development-Reference-Cited by-同舟云学术

Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development

Published:2018-04-27 Issue:12 Volume:34 Page:2031-2039
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Seo Jaein¹,Smith B. Douglas²,Estey Elihu³⁴,Voyard Ernest⁵,O’ Donoghue Bernadette⁵,Bridges John F. P.¹

Affiliation:

1. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;

2. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA;

3. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;

4. Department of Medical Oncology, University of Washington, Seattle, WA, USA;

5. The Leukemia & Lymphoma Society, Ryebrook, NY, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1456414

Reference62 articles.

1. Leukaemia update. Part 1: diagnosis and management

2. Acute myeloid leukemia in the older adults

3. Acute myeloid leukaemia

4. Cancer treatment and survivorship statistics, 2014

5. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials;Hepatology Communications;2024-05-10

2. Pretesting Discrete-Choice Experiments: A Guide for Researchers;The Patient - Patient-Centered Outcomes Research;2024-02-16

3. Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity;Value in Health;2024-02

4. Stakeholder Engagement in Designing Attributes for a Discrete Choice Experiment With Policy Implications: An Example of 2 Swiss Studies on Healthcare Delivery;Value in Health;2023-06

5. Caregivers’ engagement in pharmaceutical assessment and development: A systematic literature review;Ethics, Medicine and Public Health;2023-02